Catalyst Wire Dossier Catalyst Wire Dossier

CB-03-01 cream, 1%

CB-03-01 · Cassiopea SpA
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CB-03-01 cream, 1%, covering 2020-11-17 to 2020-11-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (26) [Phase 3]

See pricing